MedPath

辽宁王牌速效制药有限公司

Ownership
-
Established
2001-06-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

57

NMPA:57

Drug Approvals

Kitasamycin Tablets

Product Name
吉他霉素片
Approval Number
国药准字H21020095
Approval Date
Apr 2, 2021
NMPA

Aminopyrine Caffeine Tablets

Product Name
氨基比林咖啡因片
Approval Number
国药准字H21022981
Approval Date
Jan 7, 2021
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H21020043
Approval Date
Jan 7, 2021
NMPA

Multienzyme Tablets

Product Name
多酶片
Approval Number
国药准字H21020051
Approval Date
Jan 7, 2021
NMPA

Amino-polyeptide Tablets

Product Name
氨肽素片
Approval Number
国药准字H21023315
Approval Date
Jan 7, 2021
NMPA

Compound phenytoin Sodium Ephedrin Hydrochloride and Theophylline Tablets

Product Name
复方妥英麻黄茶碱片
Approval Number
国药准字H21022713
Approval Date
Jan 7, 2021
NMPA

Ephedrine Hydrochloride and Diphenhydramine Hydrochloride Tablets

Product Name
麻黄碱苯海拉明片
Approval Number
国药准字H21024111
Approval Date
Jan 7, 2021
NMPA

Methionine and Cholinie Bitartrate Tablets

Product Name
蛋氨酸重酒石酸胆碱片
Approval Number
国药准字H21023197
Approval Date
Jan 7, 2021
NMPA

Benproperine Phosphate Capsules

Product Name
磷酸苯丙哌林胶囊
Approval Number
国药准字H21022393
Approval Date
Jan 7, 2021
NMPA

Compound Aspirin Tablets

Product Name
复方乙酰水杨酸片
Approval Number
国药准字H21020723
Approval Date
Jan 7, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.